Clinical Trial Update: A Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating penciclovir 1% cream to prevent lesions in individuals with recurrent cold sores has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Labialis

Drugs mentioned

• Denavir (Penciclovir) Cream (Penciclovir)

Snippet

Sponsor: Novartis | Conditions: Cold Sore | Phase 4 | Status: COMPLETED | Results posted: 2011-01-19